Sabiad Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Sabiad General Information
Description
Developer of infection imaging technology designed to ensure better diagnosis of Staphylococcus aureus-related infections in the orthopedic implant domain. The company's theranostic technology invents upcoming technologies to enable early detection of Staphylococcus Areus (SA) infections and prevent severe impacts on patients, providing surgeons and healthcare providers with improved accuracy of diagnosis and prevention of overtreatment with antibiotics.
Contact Information
Website
www.sabiad.euCorporate Office
- L.J. Zielstraweg 1 Office 2nd floor
- 25/27
- 9713 GX Groningen
- Netherlands
Corporate Office
- L.J. Zielstraweg 1 Office 2nd floor
- 25/27
- 9713 GX Groningen
- Netherlands
Sabiad Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 19-Jan-2024 | Completed | Generating Revenue |
Sabiad Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pharma Connect Capital | Venture Capital | Minority |
Sabiad FAQs
-
When was Sabiad founded?
Sabiad was founded in 2022.
-
Where is Sabiad headquartered?
Sabiad is headquartered in Groningen, Netherlands.
-
What industry is Sabiad in?
Sabiad’s primary industry is Laboratory Services (Healthcare).
-
Is Sabiad a private or public company?
Sabiad is a Private company.
-
What is Sabiad’s current revenue?
The current revenue for Sabiad is .
-
Who are Sabiad’s investors?
Pharma Connect Capital has invested in Sabiad.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process